FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer
The new approval marks the 40th oncology indication for pembrolizumab across 19 cancer types, including two previous metastatic cervical cancer approvals.
Medscape Medical News
source https://www.medscape.com/viewarticle/fda-approves-pembrolizumab-stage-3-4a-cervical-cancer-2024a10000zt?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/fda-approves-pembrolizumab-stage-3-4a-cervical-cancer-2024a10000zt?src=rss
Comments
Post a Comment